HAEMOSTATIX LIMITED
Get an alert when HAEMOSTATIX LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-03-28 (in 10mo)
Last made up 2026-03-14
Watchouts
None on the register
Cash
£1K
-29.2% vs 2023
Net assets
-£629K
-22.4% vs 2023
Employees
—
Average over period
Profit before tax
-£115K
-9.1% vs 2023
Name history
Renamed 1 time since incorporation
- HAEMOSTATIX LIMITED 2003-03-24 → present
- HAEMOSTATICS LIMITED 2003-03-14 → 2003-03-24
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£105,378 | -£114,994 | |
| Profit before tax | -£105,378 | -£114,994 | |
| Net profit | -£105,378 | -£114,994 | |
| Cash | £1,447 | £1,024 | |
| Total assets less current liabilities | — | — | |
| Net assets | -£513,610 | -£628,604 | |
| Equity | -£513,610 | -£628,604 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Current ratio | 0.04x | 0.03x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG, Chartered Accountants
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Taking into account the support of the parent Company and, having made appropriate enquiries, the Directors have a reasonable expectation that the Company has adequate resources and has the ability to meet its liabilities as and when they fall due to allow the Company to continue in operational existence for a period of at least 12 months from the date of the financial statements. The Company therefore continues to adopt the going concern basis in preparing its financial statements.”
Significant events
- “Following an internal review of expenditure required to progress its PeproStat™ and ReadyFlow™ products, and considering future funding requirements, a decision has been taken for the Company not to fund the products beyond their current status, and to seek external partners to fund future development.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JACKSON, Alaric Richard Warwick | Director | 2026-05-08 | Oct 1976 | British |
| JAVEED, Zubair | Director | 2025-12-19 | May 1972 | British |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| APPLEBY, Jacqueline Anne | Secretary | 2004-03-01 | 2015-11-30 |
| TAYLOR, Sarah Margaret | Secretary | 2003-03-14 | 2004-03-01 |
| WATERLOW SECRETARIES LIMITED | Corporate Nominee Secretary | 2003-03-14 | 2003-03-14 |
| BARFIELD, Richard Timothy | Director | 2019-07-08 | 2023-02-03 |
| BROWN, Grahaem Walter | Director | 2007-10-01 | 2010-05-27 |
| BURNS, Robert Forbes, Dr | Director | 2008-06-19 | 2016-05-24 |
| CURTAIN, Jonathan Andrew, Mr. | Director | 2023-02-03 | 2025-07-31 |
| GEE, Charles Jonathan, Dr | Director | 2006-02-03 | 2009-05-22 |
| GOODALL, Alison Helena | Director | 2003-03-14 | 2016-05-24 |
| HIRST, Simon Matthew | Director | 2004-07-30 | 2005-04-22 |
| JAMES, Ronald, Dr. | Director | 2004-06-30 | 2016-05-24 |
| MACKIE, Andrew | Director | 2016-05-24 | 2018-10-01 |
| MIDDLETON, Sarah Margaret | Director | 2003-03-14 | 2016-07-31 |
| NICHOLS, John Benjamin, Dr | Director | 2008-02-25 | 2018-07-20 |
| RELJANOVIC, Miroslav | Director | 2016-05-24 | 2026-04-29 |
| RUEDIG, Christoph Oliver, Dr | Director | 2012-06-06 | 2016-05-24 |
| SLAGEL, Dean Marc | Director | 2014-12-15 | 2016-05-24 |
| STAMP, Stephen Anthony | Director | 2016-05-24 | 2019-07-08 |
| NEWMEDIA SPARK DIRECTORS LIMITED | Corporate Director | 2009-05-22 | 2015-11-30 |
| WATERLOW NOMINEES LIMITED | Corporate Nominee Director | 2003-03-14 | 2003-03-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ergomed Group Limited | Corporate entity | Shares 75–100% | 2016-05-26 | Active |
Filing timeline
Last 20 of 159 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-11 | AP01 | officers | Appoint person director company with name date | |
| 2026-05-11 | TM01 | officers | Termination director company with name termination date | |
| 2026-03-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-23 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-03 | AA | accounts | Accounts with accounts type full | |
| 2025-08-12 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-28 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-07 | AA | accounts | Accounts with accounts type full | |
| 2024-03-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-20 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-09-23 | AA | accounts | Accounts with accounts type full | |
| 2023-03-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-06 | TM01 | officers | Termination director company with name termination date | |
| 2023-02-06 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-12 | AA | accounts | Accounts with accounts type full | |
| 2022-03-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-21 | AA | accounts | Accounts with accounts type full | |
| 2021-03-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-10-13 | AA | accounts | Accounts with accounts type full | |
| 2020-06-30 | AD01 | address | Change registered office address company with date old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
-29.2%
£1,447 £1,024
-
Net assets
-22.4%
-£513,610 -£628,604
-
Employees
—
Not reported
-
Operating profit
-9.1%
-£105,378 -£114,994
-
Profit before tax
-9.1%
-£105,378 -£114,994
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers